164 related articles for article (PubMed ID: 16882282)
1. A prospective observational study of a cohort of outpatients with an acute medical event and reduced mobility: incidence of symptomatic thromboembolism and description of thromboprophylaxis practices.
Bosson JL; Pouchain D; Bergmann JF;
J Intern Med; 2006 Aug; 260(2):168-76. PubMed ID: 16882282
[TBL] [Abstract][Full Text] [Related]
2. [Prevalence and prevention of venous thromboembolic events in general practice. Multicenter, prospective cohort study].
Pouchain D; Bergmann JF; Bosson JL
Rev Prat; 2008 Dec; 58(19 Suppl):3-8. PubMed ID: 19253785
[TBL] [Abstract][Full Text] [Related]
3. [Rationalization of risk factors for venous thromboembolism in medical inpatients. A prospective study].
Pottier P; Planchon B; Truchaud F; Pistorius MA; Furic I; Grolleau JY
J Mal Vasc; 2000 Oct; 25(4):241-9. PubMed ID: 11060418
[TBL] [Abstract][Full Text] [Related]
4. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients.
Leizorovicz A; Cohen AT; Turpie AG; Olsson CG; Vaitkus PT; Goldhaber SZ;
Circulation; 2004 Aug; 110(7):874-9. PubMed ID: 15289368
[TBL] [Abstract][Full Text] [Related]
5. Outpatient treatment of pulmonary embolism with dalteparin.
Kovacs MJ; Anderson D; Morrow B; Gray L; Touchie D; Wells PS
Thromb Haemost; 2000 Feb; 83(2):209-11. PubMed ID: 10739374
[TBL] [Abstract][Full Text] [Related]
6. Thromboprophylaxis practice patterns in two Western Australian teaching hospitals.
Eikelboom JW; Mazzarol A; Quinlan DJ; Beaver R; Williamson J; Yi Q; Hankey GJ;
Haematologica; 2004 May; 89(5):586-93. PubMed ID: 15136222
[TBL] [Abstract][Full Text] [Related]
7. Prophylaxis against venous thromboembolism in acutely ill medical patients: an observational study.
Peterman CM; Kolansky DM; Spinler SA
Pharmacotherapy; 2006 Aug; 26(8):1086-90. PubMed ID: 16863485
[TBL] [Abstract][Full Text] [Related]
8. Risk factors and clinical impact of postoperative symptomatic venous thromboembolism.
Gangireddy C; Rectenwald JR; Upchurch GR; Wakefield TW; Khuri S; Henderson WG; Henke PK
J Vasc Surg; 2007 Feb; 45(2):335-341; discussion 341-2. PubMed ID: 17264013
[TBL] [Abstract][Full Text] [Related]
9. Optimal dosing of bemiparin as prophylaxis against venous thromboembolism in surgery for cancer: an audit of practice.
Balibrea JL; Altimiras J; Larruzea I; Gómez-Outes A; Martínez-González J; Rocha E;
Int J Surg; 2007 Apr; 5(2):114-9. PubMed ID: 17448976
[TBL] [Abstract][Full Text] [Related]
10. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
Haas S; Breyer HG; Bacher HP; Fareed J; Misselwitz F; Victor N; Weber J;
Int Angiol; 2006 Dec; 25(4):335-42. PubMed ID: 17164738
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for venous thromboembolism in the elderly: results of the master registry.
Ageno W; Agnelli G; Imberti D; Moia M; Palareti G; Pistelli R; Rossi R; Verso M;
Blood Coagul Fibrinolysis; 2008 Oct; 19(7):663-7. PubMed ID: 18832907
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the appropriateness of thromboprophylaxis in an acute care setting using a computerised reminder, through order-entry system.
Pham DQ; Pham AQ; Ullah E; McFarlane SI; Payne R
Int J Clin Pract; 2008 Jan; 62(1):134-7. PubMed ID: 17892471
[TBL] [Abstract][Full Text] [Related]
13. Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada.
Kahn SR; Panju A; Geerts W; Pineo GF; Desjardins L; Turpie AG; Glezer S; Thabane L; Sebaldt RJ;
Thromb Res; 2007; 119(2):145-55. PubMed ID: 16516275
[TBL] [Abstract][Full Text] [Related]
14. Incidence and predictors of venous thromboembolism in post-acute care patients. A prospective cohort study.
Scannapieco G; Ageno W; Airoldi A; Bonizzoni E; Campanini M; Gussoni G; Silingardi M; Valerio A; Zilli C; Iori I;
Thromb Haemost; 2010 Oct; 104(4):734-40. PubMed ID: 20664897
[TBL] [Abstract][Full Text] [Related]
15. Electronic alerts to prevent venous thromboembolism among hospitalized patients.
Kucher N; Koo S; Quiroz R; Cooper JM; Paterno MD; Soukonnikov B; Goldhaber SZ
N Engl J Med; 2005 Mar; 352(10):969-77. PubMed ID: 15758007
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for recurrent events in subjects with superficial vein thrombosis in the randomized clinical trial SteFlux (Superficial Thromboembolism Fluxum).
Cosmi B; Filippini M; Campana F; Avruscio G; Ghirarduzzi A; Bucherini E; Camporese G; Imberti D; Legnani C; Palareti G;
Thromb Res; 2014 Feb; 133(2):196-202. PubMed ID: 24365043
[TBL] [Abstract][Full Text] [Related]
17. Use of venous thromboembolism prophylaxis for surgical patients: a multicentre analysis of practice in Spain.
Otero R; Uresandi F; Cayuela A; Blanquer J; Cabezudo MA; De Gregorio MA; Lobo JL; Nauffal D; Oribe M
Eur J Surg; 2001 Mar; 167(3):163-7. PubMed ID: 11316398
[TBL] [Abstract][Full Text] [Related]
18. Venous thromboembolic risk and its prevention in hospitalized medical patients.
Haas SK
Semin Thromb Hemost; 2002 Dec; 28(6):577-84. PubMed ID: 12536351
[TBL] [Abstract][Full Text] [Related]
19. The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients.
Prandoni P; Villalta S; Bagatella P; Rossi L; Marchiori A; Piccioli A; Bernardi E; Girolami B; Simioni P; Girolami A
Haematologica; 1997; 82(4):423-8. PubMed ID: 9299855
[TBL] [Abstract][Full Text] [Related]
20. Venous thromboembolism in patients undergoing shoulder surgery: findings from the RECOS Registry.
Imberti D; Ivaldo N; Murena L; Paladini P; Castagna A; Barillari G; Guerra E; Fama G; Castoldi F; Marelli B; Pierfranceschi MG; Camporese G; Dentali F; Porcellini G;
Thromb Res; 2014 Aug; 134(2):273-7. PubMed ID: 24916548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
